Eam Investors, LLC Amicus Therapeutics, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $448,125 - $581,833	-45,634 Reduced 21.32%	168,399 $1.76 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $1.33 Million - $2.38 Million	214,033 New	214,033 $2.3 Million
Q1 2021 May 11, 2021	SELL	$9.2 - $23.86 $808,514 - $2.1 Million	-87,882 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$13.47 - $24.89 $1.18 Million - $2.19 Million	87,882 New	87,882 $2.03 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.